Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Updated on: April 28,2024

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Updated on:April 28,2024

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on: August 03,2024

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on:August 03,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on: January 30,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on:January 30,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Researchers show that using a tumor's own bacteria is a promising anticancer therapy

by Japan Advanced Institute of Science and TechnologyA bacterial consortium consisting of A-gyo, UN-gyo, and AUN has high anticancer efficacy, triggering the immune system to attack tumor cells. Credi

Updated on: February 24,2024

Researchers show that using a tumor's own bacteria is a promising anticancer therapy

by Japan Advanced Institute of Science and TechnologyA bacterial consortium consisting of A-gyo, UN-gyo, and AUN has high anticancer efficacy, triggering the immune system to attack tumor cells. Credi

Updated on:February 24,2024

Suicide risk more than quadruples for people with cancer

by Pennsylvania State UniversityCredit: CC0 Public DomainPeople with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of M

Updated on: March 06,2024

Suicide risk more than quadruples for people with cancer

by Pennsylvania State UniversityCredit: CC0 Public DomainPeople with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of M

Updated on:March 06,2024

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin

Updated on: February 24,2024

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin

Updated on:February 24,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on: February 01,2024

Care at high-volume radiation treatment centers tied to higher survival

by Lori SolomonAmong men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug.

Updated on:February 01,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on: February 01,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on:February 01,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang

Updated on: September 28,2024

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang

Updated on:September 28,2024